Evidence map›Paper›PMID 29148570›Full record

ArticleMedical physics2018

Robust optimization in IMPT using quadratic objective functions to account for the minimum MU constraint.

Jie Shan, Yu An, Martin Bues, Steven E Schild, Wei Liu

Abstract read
In one paragraph

Article in Medical physics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. AI in Proton Therapy Treatment Planning: A Narrative Review.International journal of particle therapy · 2026
    Article
  2. [Molecular Mechanism of microRNA-429 TargetingSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. [miR-2110 Affects the Biological Behaviors of Lung Adenocarcinoma by Regulating CDT1].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Medical physics · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jie ShanDepartment of Biomedical Informatics, Arizona State University, Tempe, AZ, USA.
Yu AnDepartment of Radiation Oncology, Mayo Clinic Hospital, Phoenix, AZ, USA.
Martin BuesDepartment of Radiation Oncology, Mayo Clinic Hospital, Phoenix, AZ, USA.
Steven E SchildDepartment of Radiation Oncology, Mayo Clinic Hospital, Phoenix, AZ, USA.
Wei LiuDepartment of Radiation Oncology, Mayo Clinic Hospital, Phoenix, AZ, USA.

Funding

4D Robust Optimization in Intensity-Modulated Proton TherapyK25CA168984 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIU, WEI · 2012 to 2015
$450k
NCI NIH HHS K25 CA168984
6 · The paper itself

Abstract

purposeCurrently, in clinical practice of intensity-modulated proton therapy (IMPT), the influence of the minimum monitor unit (MU) constraint is taken into account through postprocessing after the optimization is completed. This may degrade the plan quality and plan robustness. This study aims to mitigate the impact of the minimum MU constraint directly during the plan robust optimization. METHODS AND MATERIALS: Cao et al. have demonstrated a two-stage method to account for the minimum MU constraint using linear programming without the impact of uncertainties considered. In this study, we took the minimum MU constraint into consideration using quadratic optimization and simultaneously had the impact of uncertainties considered using robust optimization. We evaluated our method using seven cancer patients with different machine settings.

resultThe new method achieved better plan quality than the conventional method. The D

conclusionOur new method of incorporating the minimum MU constraint directly into the plan robust optimization can produce machine-deliverable plans with better tumor coverage while maintaining high-plan robustness.

Indexed as

AlgorithmsHead and Neck NeoplasmsHumansLung NeoplasmsMaleProstatic NeoplasmsRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRetrospective StudiesTime FactorsTomography, X-Ray Computeddeliverable robustnessintensity-modulated proton therapy (IMPT)L-BFGS-Bminimum MU constraintquadratic optimization

Identifiers

PMID29148570
PMCPMC5774242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.